Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2018-11-08
Original SEC Filing: Click here

---

Webplus: SVA/20181108/6-K_1/2_EX-99.1/000.htm SEC Original: tv506700_ex99-1.htm
Sinovac Reports Unaudited First Half of 2018 Financial Results BEIJING, China, November 8, 2018 /PRNewswire/ — Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the six months ended June 30, 2018. Financial highlights Ÿ Sales revenue for the first six months of 2018 was

---

---

Webplus: SVA/20181108/6-K_1/1/000.htm SEC Original: tv506700_6k.htm

---

Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2018-11-08CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 15 ZHI TONG ROAD,, ZHONGGUANCUN TECH PARK, CHANGPING DISTR.
BEIJING 102200